Encompass Health Corporation Common Stock (EHC)
Encompass Health Corporation (EHC) is a leading provider of post-acute healthcare services, specializing in inpatient rehabilitation and home-based care. The company operates a network of inpatient rehabilitation hospitals and offers comprehensive outpatient rehabilitation services, focusing on helping patients recover from serious injuries, surgeries, and illnesses. Encompass Health emphasizes integrated care delivery to improve patient outcomes across the continuum of care.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 15, 2025 | $0.19 | 2025-10-01 | 2025-10-01 |
| July 15, 2025 | $0.17 | 2025-07-01 | 2025-07-01 |
| April 15, 2025 | $0.17 | 2025-04-01 | 2025-04-01 |
| January 15, 2025 | $0.17 | 2025-01-02 | 2025-01-02 |
| October 15, 2024 | $0.17 | 2024-10-01 | 2024-10-01 |
Dividends Summary
- Encompass Health Corporation Common Stock has issued 50 dividend payments over the past 16 years
- The most recent dividend was paid 7 days ago, on October 15, 2025
- The highest dividend payed out to investors during this period was $0.55 per share
- The average dividend paid during this period was $0.23 per share.
Company News
Rosen Law Firm is investigating potential securities claims for Encompass Health shareholders following a New York Times article alleging serious patient safety incidents and below-average performance in rehabilitation hospitals.
Five stocks are delivering strong total returns in 2025 by increasing their dividends by 10% or more, demonstrating commitment to shareholder value through consistent dividend growth and impressive stock performance.
Encompass Health reported strong Q2 2025 financial results, with revenue of $1.46 billion and non-GAAP EPS of $1.40, exceeding analyst expectations. The company saw growth in patient discharges and improved operational efficiency, leading to raised full-year guidance.
HCA Healthcare reported strong Q2 2024 results, with adjusted EPS of $5.50 beating estimates and revenues of $17.5 billion growing 10.3% year-over-year. The company benefited from rising admissions and higher inpatient and outpatient surgeries, though rising expenses partially offset the positives.
Analysts have published 6 ratings on Encompass Health in the last 3 months, with an average 12-month price target of $97.83 and a positive shift in sentiment compared to the previous average.